Your browser doesn't support javascript.
loading
A Novel B7-H6-Targeted IgG-Like T Cell-Engaging Antibody for the Treatment of Gastrointestinal Tumors.
Zhang, Wei; Auguste, Aurélie; Liao, Xiaoyun; Walterskirchen, Christian; Bauer, Kathrin; Lin, Yu-Hsi; Yang, Ling; Sayedian, Farzaneh; Fabits, Markus; Bergmann, Michael; Binder, Carina; Corrales, Leticia; Vogt, Anne B; Hudson, Lindsey J; Barnes, Martin P; Bisht, Arnima; Giragossian, Craig; Voynov, Vladimir; Adam, Paul J; Hipp, Susanne.
Afiliación
  • Zhang W; Boehringer Ingelheim Pharmaceuticals, Inc., Cancer Immunology & Immune Modulation, Ridgefield, Connecticut.
  • Auguste A; Boehringer Ingelheim Pharma, GmbH & Co KG, Translational Medicine and Clinical Pharmacology, Biberach an der Riß, Germany.
  • Liao X; Boehringer Ingelheim Pharmaceuticals, Inc., Oncology Translational Science, Ridgefield, Connecticut.
  • Walterskirchen C; Boehringer Ingelheim RCV, GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Bauer K; Boehringer Ingelheim RCV, GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Lin YH; Boehringer Ingelheim Pharmaceuticals, Inc., Cancer Immunology & Immune Modulation, Ridgefield, Connecticut.
  • Yang L; Boehringer Ingelheim Pharmaceuticals, Inc., Cancer Immunology & Immune Modulation, Ridgefield, Connecticut.
  • Sayedian F; Roche Tissue Diagnostics, Tucson, Arizona.
  • Fabits M; Medical University of Vienna, Division of Visceral Surgery, Department of General Surgery and Comprehensive Cancer Center, Vienna, Austria.
  • Bergmann M; Medical University of Vienna, Division of Visceral Surgery, Department of General Surgery and Comprehensive Cancer Center, Vienna, Austria.
  • Binder C; Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Corrales L; Boehringer Ingelheim RCV, GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Vogt AB; Boehringer Ingelheim RCV, GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Hudson LJ; Oxford BioTherapeutics, Ltd., Oxon, United Kingdom.
  • Barnes MP; Oxford BioTherapeutics, Ltd., Oxon, United Kingdom.
  • Bisht A; Oxford BioTherapeutics, Inc., San Jose, California.
  • Giragossian C; Boehringer Ingelheim Pharmaceuticals, Inc., Biotherapeutics Discovery, Ridgefield, Connecticut.
  • Voynov V; Boehringer Ingelheim Pharmaceuticals, Inc., Biotherapeutics Discovery, Ridgefield, Connecticut.
  • Adam PJ; Boehringer Ingelheim RCV, GmbH & Co KG., Cancer Immunology & Immune Modulation, Vienna, Austria.
  • Hipp S; Boehringer Ingelheim Pharmaceuticals, Inc., Cancer Immunology & Immune Modulation, Ridgefield, Connecticut.
Clin Cancer Res ; 28(23): 5190-5201, 2022 12 01.
Article en En | MEDLINE | ID: mdl-36166004
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias Gastrointestinales Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias Gastrointestinales Límite: Animals / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article